Delivery Order SPE2DE24D0013-SPE2D626F06UJ
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $20.4K to Cepheid Inc. on January 13, 2026, for diagnostic testing supplies and reagents. This delivery order, designated XPRS4PLEX-10, is a child contract under a larger Indefinite Delivery Vehicle and carries a firm fixed-price structure with no set-aside designation. The order is scheduled for completion by January 21, 2026, and will be performed at Cepheid's headquarters location in Sunnyvale, California....
- The Defense Logistics Agency Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on December 8, 2025, with an ultimate completion date of December 15, 2025. This delivery order, designated XPRS4PLEX-10, represents a small procurement of diagnostic reagents and test kits for Cepheid's GeneXpert diagnostic platform. The contract carries no set-aside designation and is being performed at Cepheid's headquarters location in Sunnyvale, California. As a leading federal...
- The Department of Defense Medical Supply Chain (Defense Logistics Agency) awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $27,863.40 on January 8, 2026. This delivery order, issued under the contract number 4570456612 (XPRS4PLEX-10), is a child award under a larger indefinite delivery vehicle and calls for diagnostic reagents and test kits for the GeneXpert diagnostic platform. The contract carries no set-aside...
- The Defense Logistics Agency Medical Supply Chain awarded a $5,440 delivery order to Cepheid Inc. on January 8, 2026, for molecular diagnostic reagents and test kits under a firm fixed-price structure. This delivery order, designated XPRS4PLEX-10, is scheduled for completion by January 15, 2026, and represents a child order under a larger indefinite delivery contract vehicle. The work will be performed at Cepheid's headquarters in Sunnyvale, California. No set-aside designation was used for this...
- Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California, was awarded a delivery order valued at $5,099.70 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRS4PLEX-10, represents procurement of diagnostic reagents and test kits—specifically XPRS4PLEX-10 cartridges designed for the GeneXpert diagnostic platform. The contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,160 to Cepheid Inc. on January 14, 2026, for diagnostic testing supplies under the XPRS4PLEX-10 contract vehicle. This firm fixed-price delivery order, with an ultimate completion date of January 22, 2026, represents a child order issued against Cepheid's larger Indefinite Delivery Contracts with the Department of Veterans Affairs. The award carries no set-aside designation, reflecting Cepheid's competitive...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California, a delivery order valued at $3,400 under contract XPRS4PLEX-10 on January 9, 2026. This firm fixed-price delivery order, with an ultimate completion date of January 16, 2026, is a child contract issued without set-aside designation and represents procurement of diagnostic testing supplies for federal healthcare operations. The award falls...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on December 2, 2025, under contract 4570154100 (XPRS4PLEX-10) with an ultimate completion date of December 9, 2025. This delivery order, which received no set-aside designation, is for diagnostic testing supplies and reagents to be delivered to the place of performance in Sunnyvale, California. Cepheid, a leading federal supplier of molecular diagnostic systems headquartered in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $8,160 delivery order (4570311575 | XPRS4PLEX-10) by the Defense Logistics Agency's Medical Supply Chain on December 15, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, falls under a larger single-award Indefinite Delivery Contract valued at $6.7 million with the Department of Veterans...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F06UJDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $81.6K firm fixed-price delivery order to Cepheid Inc. on January 14, 2026, for diagnostic reagents and test kits under the XPRS4PLEX-10 contract vehicle. This delivery order, which is a child contract under a larger Indefinite Delivery Vehicle, is scheduled for completion by January 22, 2026, and will be performed at Cepheid's headquarters in Sunnyvale, California. No small business set-aside was utilized for this procurement. Cepheid, a leading manufacturer of molecular diagnostic systems, has established itself as a primary federal supplier of diagnostic solutions, particularly through its GeneXpert diagnostic platform capabilities for detecting infectious diseases including COVID-19, influenza, respiratory pathogens, and other clinical conditions. This delivery order reflects Cepheid's significant role as a core supplier to the federal healthcare system, supported by the company's extensive contract portfolio across multiple agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. Cepheid currently holds two substantial Indefinite Delivery Contracts with the VA—one valued at $6.7M through VISN 17 and another valued at $32.8M through VISN 6, both extending through 2029-2030—which serve as the primary vehicles for procuring molecular diagnostic testing system reagents, assays, and related services across the federal healthcare network. The firm fixed-price structure and consistent award patterns demonstrate Cepheid's competitive positioning and the government's reliance on the company's diagnostic capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $81.6k | 1/13/26 |